MASTER AGREEMENTMaster Agreement • March 21st, 2011 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • North Carolina
This Master Agreement, effective as of December 15, 2010 (the “Effective Date”), is entered by and between Oxygen Biotherapeutics, Inc., with its principal place of business at 2530 Meridian Parkway, Suite 3078, Durham, NC 27713 (“OBI”) and Dermacyte Switzerland Ltd. with a place of business located at EtzelbIickstrasse I, 8834 Schindellegi, Switzerland (“Company”).
AMENDMENT No. 1 TO MASTER AGREEMENTMaster Agreement • March 21st, 2011 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research
This Amendment No.1 to Master Agreement (“Amendment”) is made and entered into as of December 16, 2010 by and between Oxygen Biotherapeutics, Inc., including its directors, officers, employees and agents (“OBI") and Dermacyte Switzerland, Ltd including its directors, officers, employees and agents (“DSL”).
